# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-17-006956
Filing Date
2017-06-29
Accepted
2017-06-29 14:56:02
Documents
35
Period of Report
2017-06-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | f6k062917_therapixbio.htm | 6-K | 10882
2 | COMPANY PRESENTATION | f6k062917ex99i_therapixbio.htm | EX-99.1 | 30312
3 | GRAPHIC | slide1.jpg | GRAPHIC | 229546
4 | GRAPHIC | slide2.jpg | GRAPHIC | 300264
5 | GRAPHIC | slide3.jpg | GRAPHIC | 157647
6 | GRAPHIC | slide4.jpg | GRAPHIC | 106168
7 | GRAPHIC | slide5.jpg | GRAPHIC | 95048
8 | GRAPHIC | slide6.jpg | GRAPHIC | 123876
9 | GRAPHIC | slide7.jpg | GRAPHIC | 130409
10 | GRAPHIC | slide8.jpg | GRAPHIC | 128967
11 | GRAPHIC | slide9.jpg | GRAPHIC | 145980
12 | GRAPHIC | slide10.jpg | GRAPHIC | 274042
13 | GRAPHIC | slide11.jpg | GRAPHIC | 82542
14 | GRAPHIC | slide12.jpg | GRAPHIC | 91851
15 | GRAPHIC | slide13.jpg | GRAPHIC | 210982
16 | GRAPHIC | slide14.jpg | GRAPHIC | 244023
17 | GRAPHIC | slide15.jpg | GRAPHIC | 101957
18 | GRAPHIC | slide16.jpg | GRAPHIC | 136903
19 | GRAPHIC | slide17.jpg | GRAPHIC | 138536
20 | GRAPHIC | slide18.jpg | GRAPHIC | 125792
21 | GRAPHIC | slide19.jpg | GRAPHIC | 271160
22 | GRAPHIC | slide20.jpg | GRAPHIC | 166016
23 | GRAPHIC | slide21.jpg | GRAPHIC | 107322
24 | GRAPHIC | slide22.jpg | GRAPHIC | 274694
25 | GRAPHIC | slide23.jpg | GRAPHIC | 121384
26 | GRAPHIC | slide24.jpg | GRAPHIC | 316989
27 | GRAPHIC | slide25.jpg | GRAPHIC | 100330
28 | GRAPHIC | slide26.jpg | GRAPHIC | 230663
29 | GRAPHIC | slide27.jpg | GRAPHIC | 173321
30 | GRAPHIC | slide29.jpg | GRAPHIC | 263239
31 | GRAPHIC | slide30.jpg | GRAPHIC | 277533
32 | GRAPHIC | slide31.jpg | GRAPHIC | 145082
33 | GRAPHIC | slide32.jpg | GRAPHIC | 124368
34 | GRAPHIC | slide33.jpg | GRAPHIC | 246061
35 | GRAPHIC | slide34.jpg | GRAPHIC | 89041
| Complete submission text file | 0001213900-17-006956.txt |  | 7940021

Mailing Address 5 AZRIELI CENTER (SQUARE TOWER) TEL-AVIV L3 6702501
Business Address 5 AZRIELI CENTER (SQUARE TOWER) TEL-AVIV L3 6702501 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 17937952
SIC: 2834 Pharmaceutical Preparations